The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Global Adult Vaccines Market – A Vital Step towards Disease Prevention Vaccines refer to the biological preparation that improves immunity to fight against a particular disease. Vaccines comprise suspen... Read more
Tapentadol - Become Pain Free! Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative ... Read more
Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromo... Read more
Opioids Market – Insights Opioids are used for pain relief, suppression of diarrhea, anesthesia, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. Opioids act on op... Read more
Medical Adhesives and Sealants Market – Providing Adhesive Solutions Post Surgeries Medical adhesives and sealants are commonly employed in medical practices for appliance bonding and surgical procedure... Read more
Clinical Nutrition – The New Tradition is Good Nutrition Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vit... Read more
Medical Tourism Market – Insights The lack of medical insurance is the primary reason driving the growth of the global medical tourism market. Expansion of internet and online advertising in rural are... Read more
Chagas Disease Treatment Market - Insights Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-suck... Read more
Rx Medical Food Market – Insights Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestina... Read more
Anti-epileptic Drugs for Pediatrics Market– Insights Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of t... Read more
Myelodysplastic Syndrome Treatment Market Insights Rising public awareness about Myelodysplastic Syndromes (MDS) and its early diagnosis and availability of new treatment options for MDS are expected to drive... Read more
Aptamers Market – Insights Aptamers are short single-stranded DNA or RNA (ssDNA or ssRNA) molecules that bind to a specific target protein, lipid, or nucleic acid molecules with high specificity. Apta... Read more
Gunshot Injuries Treatment Market: Life Saviors at the Battlefield Gunshot injury, also referred to as ballistic trauma, is a form of physical trauma caused when a bullet, knife or any sharp projectile is sho... Read more
Epistaxis Market– Insights Epistaxis, also known as nosebleed, occurs due to rupture of small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive. Al... Read more
Global Active Pharmaceutical Ingredients Market API is a main ingredient, which helps to cure a disease or disorder. APIs provide health benefits and are used in disease diagnosis, prevention, and treatment. ... Read more
Global Transthyretin Amyloidosis Treatment Market – Insights Hereditary transthyretin amyloidosis (hATTR) and wild type transthyretin amyloidosis are two main types of transthyretin amyloidosis. hATTR i... Read more
Parenteral Packaging Market – Insights Parenteral packaging is the process of packaging drugs or other fluids to keep their potency and therapeutic effectiveness intact till the drug is administered. ... Read more
Generic Oncology Sterile Injectable Market – Insights Generic oncology sterile injectables are biologics that have the same active ingredients as that of the branded version, with only the inactive co... Read more